Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7371 p473
15 October 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Build strong relationships with GPs and new primary care trusts

John D'Arcy

John D’Arcy: understand the agenda

Pharmacists will need to forge stronger relationships with GPs and with reconfigured primary care trusts if the profession is to make the most of practice-based commissioning, according to John D'Arcy, chief executive of the National Pharmacy Association.

Speaking at the annual conference of the National Association of Co-operative Executive Pharmacists in Stratford-upon-Avon last week, Mr D’Arcy warned that pharmacists would have to get to grips with practice-based commissioning.

“ We need to understand the agenda. Delay is not an option. We have got to bed down the essential and advanced services,” he said. “And we have to build relationships with GPs and the new PCTs. Yes, the reorganisation means that PCTs are not engaged but time is not a luxury we have.

“So, be opportunistic and engage with them now by offering services that meet the needs of the local agenda.”

Sue Sharpe, chief executive of the Pharmaceutical Services Negotiating Committee, agreed that pharmacists should concentrate on providing essential and advanced services while PCTs are reconfigured. “Let us recognise that this is not the right time for commissioning enhanced services,” she told conference delegates.

Meanwhile, a survey conducted by NHS Alliance and the Health Service Journal has suggested that the planned reorganisation of PCTs (PJ, 6 August, p156) could adversely affect the delivery of health care services. It asked PCT professional executive committee chairmen for their views on the impact of the reconfiguration.

Over three-quarters of the 102 who responded said that “local circumstances and patient needs” were not getting proper consideration in the process. Four out of five (80 per cent) said that clinical engagement with other groups of health professionals providing primary care services would be weakened.


News feature p476

Back to Top


©The Pharmaceutical Journal